Features of primary extranodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan

Medical Oncology

Volumn 26, Issue 1, 2009, Pages 49-54

  Fujita, Atsuko ^a   Tomita, Naoto ^b   Fujita, Hiroyuki ^c   Motohashi, Kenji ^a   Hyo, Rie ^a   Yamazaki, Etsuko ^d   Hattori, Michiko ^e   Fujisawa, Shin ^a   Kanamori, Heiwa ^b   Ogawa, Koji ^f   Motomura, Shigeki ^g   Kodama, Fumio ^g   Ishigatsubo, Yoshiaki ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c SHIZUOKA RED CROSS HOSPITAL   (Japan)

^d Fujisawa City Hospital   (Japan)

^e Yokohama Ekisaikai Hospital   (Japan)

^f Yokosuka City Hospital   (Japan)

^g KANAGAWA CANCER CENTER   (Japan)

Author keywords

Diffuse large B cell lymphoma; Extranodal lymphoma; Japan; Primary site; WHO classification

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BONE; BONE MARROW; BREAST; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; CONTROLLED STUDY; EXTRANODAL LYMPHOMA; FEMALE; FOLLICULAR LYMPHOMA; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; JAPAN; LARGE CELL LYMPHOMA; LUNG; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NOSE CAVITY; ORBIT; OVARY; PARANASAL SINUS; PLEURA; PRIORITY JOURNAL; PROSTATE; SALIVARY GLAND; SKIN; SOFT TISSUE; SUBCUTANEOUS TISSUE; TESTIS; THYROID GLAND; UTERUS; WALDEYER RING; WORLD HEALTH ORGANIZATION; AGE; CANCER STAGING; GASTROINTESTINAL TUMOR; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MIDDLE AGED; PATHOLOGY; PREVALENCE; SURVIVAL RATE; TONSIL TUMOR; VIROLOGY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAPAN; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; SURVIVAL RATE; TONSILLAR NEOPLASMS;

EID: 65549164435     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9080-0     Document Type: Article

References (21)

1. PP Carbone HS Kaplan K Musshoff DW Smithers M Tubiana 1971 Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res. 31 1860 1
2. Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization Classification of Tumours. Lyon: IARC Press; 2001.
3. A predictive model for aggressive non-Hodgkin's lymphoma: the International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med. 1993;329:987-94. doi: 10.1056/NEJM199309303291402. (Pubitemid 23307906)
4. C Freeman JW Berg SJ Cutler 1972 Occurrence and prognosis of extranodal lymphomas Cancer. 29 252 60 10.1002/1097-0142(197201)29:1≥252::AID- CNCR2820290138≥3.0.CO;2-#
5. Sutcliff SB, Gospodarowicz MK. Clinical features and management of localized extranodal lymphomas. In: Keating A, Armitage J, Burnet A, Newland A, editors. Haematological oncology, vol 2. Cambridge: Cambridge University Press; 1992. p. 189-223.
6. Ahmad M, Malik IA. Non-Hodgkin's lymphoma in developing countries. In: Magrath IT, editor. The Non-Hodgkin's lymphomas, 2nd ed. London: Arnold; 1997. p. 1031-54.
7. F d'Amore BE Christensen H Brincker 1991 Clinicopathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Danish LYFO Study Group Eur J Cancer. 27 1201 8
8. R Otter WB Gerrits MMVD Sandt J Hermans R Willemze 1989 Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry Eur J Cancer Clin Oncol. 25 1203 10 10.1016/0277-5379(89)90416-1 (Pubitemid 19209616)
9. T Takagi 1999 Clinical features of extranodal malignant lymphoma-staging classification and treatment strategies Rinsho Ketsueki. 40 188 91
10. Nitsu N, Okamoto M. Activities and analysis. In: Adult lymphoma treatment study group, editors. Malignant lymphoma clinical and pathology. Tokyo: Sentan-igakusha; 2005. p. 14-28.
11. E Zucca E Roggero F Bertoni A Conconi F Cavalli 1999 Primary extranodal non-Hodgkin's lymphomas. Part 2: head and neck, central nervous system and other less common sites Ann Oncol. 10 1023 33 10.1023/A:1008313229892 (Pubitemid 29482456)
12. MB Moller NT Pedersen BE Christensen 2004 Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation-a population-based study of 1575 cases Br J Haematol. 124 151 9 10.1046/j.1365-2141.2003.04749.x (Pubitemid 38122186)
13. SS Devesa T Fears 1992 Non-Hodgkin's lymphoma time trends: United States and international data Cancer Res. 52 5432s 40s
14. FD Groves MS Linet LB Travis SS Devesa 2000 Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995 J Natl Cancer Inst. 92 1240 51 10.1093/jnci/92.15.1240
15. E Zucca E Roggero F Bertoni F Cavalli 1997 Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas Ann Oncol. 8 727 37 10.1023/A:1008282818705 (Pubitemid 27397895)
16. DD Weisenburger 1994 Epidemiology of non-Hodgkin's lymphoma: recent findings regarding an emerging epidemic Ann Oncol. 5 19s 24s
17. PH Levine RN Hoover 1992 The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding aetiologic factors Cancer Res. 52 5425s 574s
18. WS Xu FC Ho J Ho AC Chan G Srivastava 1997 Pathogenesis of gastric lymphoma: the enigma in Hong Kong Ann Oncol. 8 41 4 10.1023/A:1008265829249
19. M Luppi 1996 Additional neoplasms and HCV infection in low-grade lymphoma of MALT type Br J Haematol. 94 373 5 10.1046/j.1365-2141.1996.d01-1791.x
20. A López-Guillermo 2005 Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin J Clin Oncol. 23 2797 804 10.1200/JCO.2005.07.155 (Pubitemid 46179470)
21. V Bogomolski-Yahalom 1998 Intravascular lymphomatosis-an indolent or aggressive entity? Leuk Lymphoma. 29 585 93 10.3109/10428199809050918